Paper Details

  1. Home
  2. Paper Details

[Treatment of cutaneous T-cell lymphomas with bexarotene].

Author: AceboElvira, Díaz-PérezJosé L, EguinoPatricia, IzuRosa, LasaOlatz

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study examined the use of bexarotene for the treatment of CTCLs refractory to at least one prior systemic therapy.
Paper Details　
Original Abstract of the Article :
The choice of treatment in cutaneous T-cell lymphomas (CTCLs) depends on the clinical stage of the disease and the patient's general condition. To date, there is no curative treatment for this disease, and the objective is to control the symptoms and prevent the disease from progressing. Bexarotene ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0001-7310(05)73155-0

データ提供：米国国立医学図書館（NLM）

Bexarotene: A Treatment Option for Cutaneous T-Cell Lymphomas

Cutaneous T-cell lymphoma (CTCL) is a complex and challenging disease, much like a vast and unforgiving desert. Researchers are continually seeking new and effective treatments to manage this type of lymphoma. This study focuses on the use of bexarotene, an X receptor-specific retinoid, as a treatment option for CTCL patients who have not responded to other systemic therapies. Bexarotene has demonstrated anti-tumor activity, making it a promising candidate for managing CTCL. The researchers delve into the rationale for using bexarotene in CTCL, highlighting its potential role in controlling symptoms and preventing disease progression.

A New Weapon in the Fight Against CTCL

The study offers hope for CTCL patients who have not responded to other treatments. Bexarotene represents a new weapon in the fight against this challenging disease, much like a desert traveler might find a hidden oasis offering a source of relief. The researchers emphasize that while there is no cure for CTCL, bexarotene can play a significant role in managing symptoms and improving patients' quality of life.

Understanding the Potential Benefits

This study provides valuable information for CTCL patients and their healthcare providers, highlighting the potential benefits of bexarotene as a treatment option. It is crucial to discuss the potential benefits and risks of bexarotene with a healthcare professional to determine if it is the right treatment choice, just as a desert traveler would consult a guide to navigate the complex landscape.

Dr.Camel's Conclusion

This study offers a promising new approach to managing CTCL, highlighting the potential of bexarotene as a treatment option for patients who have not responded to other therapies. It underscores the importance of ongoing research to discover new and effective treatments for this challenging disease, much like a desert traveler tirelessly searching for a hidden oasis.

Date :
  1. Date Completed 2006-05-24
  2. Date Revised 2019-11-09
Further Info :

Pubmed ID

16476317

DOI: Digital Object Identifier

10.1016/s0001-7310(05)73155-0

Related Literature

Article Analysis
・Side Effects of bexarotene
SNS
PICO Info
in preparation
Languages

Spanish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.